Hair Diseases Market

 Market Overview:

The 7 major hair diseases markets reached a value of US$ 6.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 11.6 Billion by 2034, exhibiting a growth rate (CAGR) of 6.05% during 2024-2034.

The hair diseases market has been comprehensively analyzed in IMARC's new report titled "Hair Diseases Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034". Hair diseases refer to a variety of conditions that affect the scalp and hair follicles, resulting in abnormalities in hair growth, structure, or appearance. These disorders can lead to hair loss, scalp discomfort, and cosmetic concerns. The illnesses are commonly characterized by gradual hair thinning and receding hairlines. Some common symptoms include small, pus-filled bumps or sores on the scalp, bald patches, scaling, flaking, itchiness, inflammation, redness, excessive oiliness or dryness, breakage and brittleness, scalp tenderness or pain, the development of fine, wispy hairs, etc. In a few cases, individuals suffering from the disorders may also experience changes in hair color, such as graying or whitening. The diagnosis of the conditions is mainly based on a comprehensive review of the patient's medical history, clinical features, and physical exam. Additionally, a trichoscopy, which uses a handheld device called a dermatoscope, is recommended to visualize structural and color changes in the hair shaft as well as determine the presence of scaling, broken hairs, or other abnormalities. The healthcare provider may further perform a scalp biopsy to confirm the diagnosis. 

The increasing prevalence of various associated risk factors, such as stress, traumatic events, hormonal changes, certain medications, etc., that cause a disruption in the hair growth cycle is primarily driving the hair diseases market. In addition to this, the rising incidence of autoimmune disorders, in which the body's defense system mistakenly attacks the hair follicles, resulting in patchy or widespread hair loss, is creating a positive outlook for the market. Moreover, the inflating application of platelet-rich plasma therapy, since it involves injecting concentrated platelets derived from the patient's blood into the scalp to enhance the appearance of hair, is further bolstering the market growth. Apart from this, the escalating adoption of 5-alpha reductase inhibitors, which help to inhibit the conversion of testosterone to dihydrotestosterone, thereby preventing baldness, is acting as another significant growth-inducing factor. Additionally, the emerging popularity of low-level laser devices to treat ailments by enhancing blood circulation and promoting a healthier scalp environment for hair follicles is expected to drive the market during the hair diseases forecast period.

IMARC Group's new report provides an exhaustive analysis of the hair diseases market in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. This includes treatment practices, in-market, and pipeline drugs, share of individual therapies, market performance across the seven major markets, market performance of key companies and their drugs, etc. The report also provides the current and future patient pool across the seven major markets. According to the report the United States has the largest patient pool for hair diseases and also represents the largest market for its treatment. Furthermore, the current treatment practice/algorithm, market drivers, challenges, opportunities, reimbursement scenario and unmet medical needs, etc. have also been provided in the report. This report is a must-read for manufacturers, investors, business strategists, researchers, consultants, and all those who have any kind of stake or are planning to foray into the hair diseases market in any manner.

Time Period of the Study

• Base Year: 2023
• Historical Period: 2018-2023
• Market Forecast: 2024-2034

Countries Covered

• United States
• Germany
• France
• United Kingdom
• Italy
• Spain
• Japan

Analysis Covered Across Each Country

• Historical, current, and future epidemiology scenario
• Historical, current, and future performance of the hair diseases market
• Historical, current, and future performance of various therapeutic categories in the market
• Sales of various drugs across the hair diseases market
• Reimbursement scenario in the market
• In-market and pipeline drugs

Competitive Landscape:

This report also provides a detailed analysis of the current hair diseases marketed drugs and late-stage pipeline drugs.

In-Market Drugs

• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance

Late-Stage Pipeline Drugs

• Drug Overview
• Mechanism of Action
• Regulatory Status
• Clinical Trial Results
• Drug Uptake and Market Performance
   

*Kindly note that the drugs in the above table only represent a partial list of marketed/pipeline drugs, and the complete list has been provided in the report.

Key Questions Answered in this Report:

Market Insights

• How has the hair diseases market performed so far and how will it perform in the coming years?
• What are the markets shares of various therapeutic segments in 2023 and how are they expected to perform till 2034?
• What was the country-wise size of the hair diseases market across the seven major markets in 2023 and what will it look like in 2034?
• What is the growth rate of the hair diseases market across the seven major markets and what will be the expected growth over the next ten years?
• What are the key unmet needs in the market?

Epidemiology Insights

• What is the number of prevalent cases (2018-2034) of hair diseases across the seven major markets?
• What is the number of prevalent cases (2018-2034) of hair diseases by age across the seven major markets?
• What is the number of prevalent cases (2018-2034) of hair diseases by gender across the seven major markets?
• How many patients are diagnosed (2018-2034) with hair diseases across the seven major markets?
• What is the size of the hair diseases patient pool (2018-2023) across the seven major markets?
• What would be the forecasted patient pool (2024-2034) across the seven major markets?
• What are the key factors driving the epidemiological trend of hair diseases?
• What will be the growth rate of patients across the seven major markets?

Hair Diseases: Current Treatment Scenario, Marketed Drugs and Emerging Therapies

• What are the current marketed drugs and what are their market performance?
• What are the key pipeline drugs and how are they expected to perform in the coming years?
• How safe are the current marketed drugs and what are their efficacies?
• How safe are the late-stage pipeline drugs and what are their efficacies?
• What are the current treatment guidelines for hair diseases drugs across the seven major markets?
• Who are the key companies in the market and what are their market shares?
• What are the key mergers and acquisitions, licensing activities, collaborations, etc. related to the hair diseases market?
• What are the key regulatory events related to the hair diseases market?
• What is the structure of clinical trial landscape by status related to the hair diseases market?
• What is the structure of clinical trial landscape by phase related to the hair diseases market?
• What is the structure of clinical trial landscape by route of administration related to the hair diseases market?